Documents

May 2011

• Generics Urge House Appropriators To Protect FDA Generic Drug Office Funding
• Families USA Says Vermont Law Demonstrates Health Reform's State-by-State Flexibility
• CRS: DTC Drug Ad Ban Could Worsen Public Health
• FDA Opens Enforcement, Compliance Web Portal
• Hatch Introduces Legislation To Strengthen, Expand HSAs, FSAs
• Kerry, Stabenow Bill Would Provide Additional $5 B To Reform Law's Early Retirement Program
• AMA Seeks Higher Safety Zone, Mandatory Review Thresholds For ACO Antitrust Reviews
• HHS Proposes Burdensome Regulations Reforms
• CAP Deficit Reduction Plan Includes Bolstered IPAB, Public Option, 'Active' Exchanges, Fail Safe Mechanism
• NAIC's Draft Report On Impact Of Broker/Agent Commissions And MLR
• Family Physicians Urge CMS To 'Drastically Reconsider' ACO Rule
• OSHA Publishes Compliance Tool For Residential Construction
• Senate Report Finds Financial Ties Between Sanofi And Doctors Regarding Lovenox
• Coalition of Health System CEOs Complains To CMS About ACO Proposed Rule
• Lawmakers Express Concern On Gout Drug Price Hike
• Hatch, Camp Call For Full Disclosure Of Health Law Waivers; Demand Information From HHS
• Rockefeller: Consumers Could Save Billions Thanks To Health Reform
• Senate Finance Republicans Call For CMS To Start Over On ACO Rule
• White House Strongly Opposes Bill Converting Teaching Health Centers' GME Funding To Authorized Appropriations
• Small Business Groups Strike Back, Form National Coalition To Stop Health Insurance Tax
• Medicare Trustees 'Alternative' Report Offers Worse Financial Outlook Due To Unlikely SGR Cuts
• AHA Floats Budget-Cutting Options In Bid To Avert Hospital Pay Cut
• JEC Analysis Finds Republican Budget Doubles Health Care Costs
• HRSA Issues Proposed Reg On Exclusion Of Orphan Drugs From 340B
• MSHA Chief Releases Upper Big Branch Statement